Skip to content
OpenCapital
Get started

Organogenesis Holdings Inc. ORGO Q3 2025 earnings

Reported November 6, 2025 · After market close

Revenue$150.9MMiss by $21.8M
EPS$0.18Miss by $0.03
Revenue estimate$172.7M
EPS estimate$0.21

Next report

Aug 6, 2026 (In 1 week)
Revenue estimate$54.3M
EPS estimate-$0.35

Financials

Q3 2025

Income statement

See full
Revenue$150.9M+31.0%
Operating income$20.7M+232%
Net income$21.6M+74.9%
EPS (diluted)$0.11+22.2%

Balance sheet

See full
Cash & equivalents$63.7M-32.4%
Total debt$31.6M-62.8%
Total equity$255.1M-8.4%
Total assets$509.8M+14.2%

Cash flow

See full
CapEx$2.2M-13.0%

Valuation & ratios

Valuation

as of 09/30/25
See full
Market cap$535.34M+41.2%
Enterprise value$503.19M+36.1%
P/E532.7×—
P/S1.2×+0.3×

Profitability

See full
Net margin0.2%—

Returns & leverage

See full
Return on equity0.4%—
Debt / equity0.1×-0.2×
Current ratio3.3×+0.2×

Segments

By product

See full
Grant$377.0K—

Versus estimates

Revenue

Q1 2026$36.3MMiss by $7.0MQ4 2025$225.1MBeat by $52.4M
Q3 2025$150.9MMiss by $21.8M
Q2 2025$101.0MMiss by $33.1MQ1 2025$86.7MMiss by $4.1MQ4 2024$126.7MBeat by $17.1M

Diluted EPS

Q1 2026-$0.37Miss by $0.08Q4 2025$0.31Beat by $0.10
Q3 2025$0.18Miss by $0.03
Q2 2025-$0.09Miss by $0.16Q1 2025-$0.13Miss by $0.17Q4 2024$0.04Beat by $0.07

Ask the moment Organogenesis Holdings Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Organogenesis Holdings Inc. report Q3 2025 earnings?
Organogenesis Holdings Inc. (ORGO) reported Q3 2025 earnings on November 6, 2025 after market close.
What were Organogenesis Holdings Inc.'s Q3 2025 revenue and EPS?
Organogenesis Holdings Inc. reported revenue of $150.9M and eps of $0.18 for Q3 2025.
Did Organogenesis Holdings Inc. beat estimates in Q3 2025?
Revenue missed the consensus estimate of $172.7M by $21.8M. EPS missed the consensus estimate of $0.21 by $0.03.
How did Organogenesis Holdings Inc.'s Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 31.0% from $115.2M a year earlier and eps grew 100.0% from $0.09.
Where can I find Organogenesis Holdings Inc.'s Q3 2025 SEC filings?
You can read the 8-K earnings release (0001193125-25-269654) and the 10-Q periodic report (0001193125-25-269697) directly on SEC EDGAR. The filing index links above go to sec.gov.